Oric Pharmaceuticals, Inc. ORIC AFS Securities
AFS Securities at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s afs securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s AFS securities?
- Oric Pharmaceuticals, Inc. (ORIC) reported AFS securities of $137.78M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s AFS securities changed year-over-year?
- Oric Pharmaceuticals, Inc.'s AFS securities increased by 587.6% year-over-year, from $20.04M to $137.78M.
- What does AFS securities mean?
- Debt securities classified as available-for-sale, measured at fair value with unrealized gains/losses in OCI rather than the income statement.